These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15891410)

  • 1. Neurorehabilitation in multiple sclerosis: foundations, facts and fiction.
    Thompson AJ
    Curr Opin Neurol; 2005 Jun; 18(3):267-71. PubMed ID: 15891410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in neurorehabilitation in multiple sclerosis.
    Thompson AJ
    Curr Opin Neurol; 2002 Jun; 15(3):267-70. PubMed ID: 12045723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.
    Paolucci S; Martinuzzi A; Scivoletto G; Smania N; Solaro C; Aprile I; Armando M; Bergamaschi R; Berra E; Berto G; Carraro E; Cella M; Gandolfi M; Masciullo M; Molinari M; Pagliano E; Pecchioli C; Roncari L; Torre M; Trabucco E; Vallies G; Zerbinati P; Tamburin S;
    Eur J Phys Rehabil Med; 2016 Dec; 52(6):827-840. PubMed ID: 27579581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
    Tintoré M
    Neurodegener Dis Manag; 2015; 5(6 Suppl):15-7. PubMed ID: 26611266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of neurological rehabilitation in multiple sclerosis.
    Thompson AJ
    J Rehabil Res Dev; 2000; 37(4):455-61. PubMed ID: 11028701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis.
    Anwar K; Barnes MP
    NeuroRehabilitation; 2009; 24(4):333-40. PubMed ID: 19597271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of spasticity management in multiple sclerosis. Evidence-based management strategies for spasticity treatment in multiple sclerosis.
    Haselkorn JK; Balsdon Richer C; Fry Welch D; Herndon RM; Johnson B; Little JW; Miller JR; Rosenberg JH; Seidle ME;
    J Spinal Cord Med; 2005; 28(2):167-99. PubMed ID: 15889701
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis.
    Meuth SG; Vila C; Dechant KL
    Expert Rev Neurother; 2015; 15(8):909-18. PubMed ID: 26166264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-medicinal treatments of spasticity in multiple sclerosis].
    Mailhan L; Papeix C
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S57-61. PubMed ID: 22721366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing the symptoms of multiple sclerosis: a multimodal approach.
    Crayton HJ; Rossman HS
    Clin Ther; 2006 Apr; 28(4):445-60. PubMed ID: 16750459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spasticity management in multiple sclerosis.
    Hughes C; Howard IM
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):593-604. PubMed ID: 24314678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic therapy and neurorehabilitation in multiple sclerosis.
    Kesselring J; Beer S
    Lancet Neurol; 2005 Oct; 4(10):643-52. PubMed ID: 16168933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids for the treatment of spasticity.
    Nielsen S; Murnion B; Campbell G; Young H; Hall W
    Dev Med Child Neurol; 2019 Jun; 61(6):631-638. PubMed ID: 30680713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines.
    Gold R; Oreja-Guevara C
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):55-9. PubMed ID: 24289845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurorehabilitation in multiple sclerosis].
    Sastre-Garriga J; Galán-Cartañá I; Montalbán X; Thompson A
    Neurologia; 2005 Jun; 20(5):245-54. PubMed ID: 15954034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: rehabilitation measures.
    Thompson AJ
    Semin Neurol; 1998; 18(3):397-403. PubMed ID: 9817542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature.
    O'Brien AR; Chiaravalloti N; Goverover Y; Deluca J
    Arch Phys Med Rehabil; 2008 Apr; 89(4):761-9. PubMed ID: 18374010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'.
    Gich J; Freixenet J; Garcia R; Vilanova JC; Genís D; Silva Y; Montalban X; Ramió-Torrentà L
    Mult Scler; 2015 Sep; 21(10):1344-8. PubMed ID: 25480865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis symptom management.
    Boissy AR; Cohen JA
    Expert Rev Neurother; 2007 Sep; 7(9):1213-22. PubMed ID: 17868019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do cannabinoids reduce multiple sclerosis-related spasticity?
    Thaera GM; Wellik KE; Carter JL; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2009 Nov; 15(6):369-71. PubMed ID: 19901724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.